Aplenzin Tablet, Extended Release
Product Images NDC 0187-5811

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aplenzin (NDC 0187-5811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

174mg

Aplenzin 174 mg extended-release tablets packaging label containing bupropion hydrobromide. The label shows the dosage strength of 174 mg, mentions once daily use, and includes a warning not to use with other medicines containing bupropion. The labeler is Bausch Health US, LLC. The package contains 30 tablets, and the label indicates Rx only status.*

FDA Label Image

348mg

Label for Aplenzin 348 mg extended-release tablets containing bupropion hydrobromide. The label indicates once daily oral use, the quantity of 30 tablets per bottle, and includes a warning against using with other medicines containing bupropion. Distributed by Bausch Health US, LLC, with storage instructions and contact information visible.*

FDA Label Image

522mg

Aplenzin 522 mg extended-release tablets label for oral use. The label includes the active ingredient bupropion hydrobromide and the dosage strength of 522 mg. It contains 30 tablets and is marked Rx only. The label features a warning against use with other bupropion-containing medicines and indicates it is distributed by Bausch Health US, LLC.*

FDA Label Image

Aplenzin Chemical Structure (Image 01)

Chemical structure of bupropion hydrobromide showing the molecular arrangement including a chlorophenyl group, a tert-butyl group, and hydrobromide salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.